echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Biochemistry News > Biotechnology News > New computational models determine the type of dementia

    New computational models determine the type of dementia

    • Last Update: 2022-10-19
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
      

    A computer science engineer at the University of Texas at Arlington will advance and integrate powerful deep learning methods and tools to identify the types of dementia associated with Alzheimer's disease, which in turn may help the medical community better treat these diseases
    .

    Dajiang Zhu, assistant professor in the Department of Computer Science and Engineering, will lead a five-year, $2.
    86 million project
    supported by the National Institute of Neurological Disorders and Stroke (NINDS).
    Professor Dajiang Zhu will collaborate with researchers at the University of North Carolina at Chapel Hill and the University of Georgia to focus on developing deep learning models
    for ADRD analysis.

    As the two most common types of dementia, Alzheimer's disease and dementia with Lewy bodies (LBD) account for 65% to 85% of dementia patients nationwide, or about 7.
    5 million people
    .

    Professor Dajiang Zhu said there was an important difference
    in identifying whether a patient had Alzheimer's or LBD.
    These differences can greatly affect the type of
    treatment prescribed to them.
    However, the differentiation between Alzheimer's disease and LBD is challenging because both are mixed pathological and clinical symptoms
    .

    "In this project, we will discover, define, and represent gyralnets of individuals—a computational model that integrates deep learning methods and neuroimaging markers—to describe Alzheimer's disease/LDD-related abnormalities in individual patients," Zhu said
    .

    He added that the project will eventually collect, map and analyze large-scale brain data
    for real-world clinical use.

    "Ultimately, we want to describe and summarize the deep relationships within the brain that will lead to improved predictive power between Alzheimer's disease and LBD, and we believe that with better treatment for these patients, identifying specific diseases earlier can lead to better outcomes
    .
    "

    "It makes a lot of
    sense to collect all the data that can be accumulated and use it to help society and people with these diseases.
    " "It represents the whole point
    of university research.
    "

     


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.